Insmed Pharmaceuticals

Insmed Incorporated (Nasdaq CM: INSM) is a biopharmaceutical company focused on the development of innovative inhaled pharmaceuticals for the site-specific treatment of serious lung diseases.

Select Venture Capital & Financial Partners

BioAsia Investments Celtrix Community Technology Fund Cooper Hill Partners FirstMark Capital (formerly Pequot Ventures ) Gilde Investment Management Intersouth Partners OneLiberty Ventures OrbiMed Advisors Pequot Ventures Soros Private Equity Investors LP Teknoinvest Management Ticonderoga Capital Vector Fund Management

www.insmed.com